282 related articles for article (PubMed ID: 31389630)
1. Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids.
Rizk OH; Bekhit MG; Hazzaa AAB; El-Khawass EM; Abdelwahab IA
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900086. PubMed ID: 31389630
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Alagumuthu M; Arumugam S
Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine-Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors.
Mohi El-Deen EM; Abd El-Meguid EA; Hasabelnaby S; Karam EA; Nossier ES
Molecules; 2019 Oct; 24(20):. PubMed ID: 31658631
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS
Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
[TBL] [Abstract][Full Text] [Related]
5. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877
[TBL] [Abstract][Full Text] [Related]
7. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA
Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161
[TBL] [Abstract][Full Text] [Related]
9. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety.
Li L; Okumu A; Dellos-Nolan S; Li Z; Karmahapatra S; English A; Yalowich JC; Wozniak DJ; Mitton-Fry MJ
Bioorg Med Chem Lett; 2018 Aug; 28(14):2477-2480. PubMed ID: 29871847
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
Fan BZ; Hiasa H; Lv W; Brody S; Yang ZY; Aldrich C; Cushman M; Liang JH
Eur J Med Chem; 2020 May; 193():112222. PubMed ID: 32200200
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities.
Aziz HA; El-Saghier AMM; Badr M; Abuo-Rahma GEA; Shoman ME
Mol Divers; 2022 Jun; 26(3):1743-1759. PubMed ID: 34455532
[TBL] [Abstract][Full Text] [Related]
15. Design of (quinolin-4-ylthio)carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing.
Metelytsia L; Hodyna D; Dobrodub I; Semenyuta I; Zavhorodnii M; Blagodatny V; Kovalishyn V; Brazhko O
Comput Biol Chem; 2020 Apr; 85():107224. PubMed ID: 32018168
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor.
Abdullah MI; Mahmood A; Madni M; Masood S; Kashif M
Bioorg Chem; 2014 Jun; 54():31-7. PubMed ID: 24747187
[TBL] [Abstract][Full Text] [Related]
17. Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study.
Ammar YA; Micky JA; Aboul-Magd DS; Abd El-Hafez SMA; Hessein SA; Ali AM; Ragab A
Chem Biol Drug Des; 2023 Feb; 101(2):245-270. PubMed ID: 36305722
[TBL] [Abstract][Full Text] [Related]
18. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA
Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates.
Haiba NS; Khalil HH; Moniem MA; El-Wakil MH; Bekhit AA; Khattab SN
Bioorg Chem; 2019 Aug; 89():103013. PubMed ID: 31174040
[TBL] [Abstract][Full Text] [Related]
20. Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity.
Liu H; Xia DG; Chu ZW; Hu R; Cheng X; Lv XH
Bioorg Chem; 2020 Jul; 100():103907. PubMed ID: 32413631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]